跳至主要内容
临床试验/NCT05818644
NCT05818644已完成不适用

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children: a Multicenter, Retrospective, Observational Study

University Medical Center Groningen1 个研究点 分布在 1 个国家目标入组 583 人开始时间: 2023年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
583
试验地点
1
主要终点
Graft survival

研究概览

简要总结

The goal of this observational study is to investigate the incidence, current management practices, and outcomes in pediatric patients with HAC after liver transplantation.

Research question:

  • What are the overall incidence of HAC and the effectiveness of all treatment strategies for HAC after pediatric LT?
  • What are the current management practices in the experience of centers, anticoagulant therapy, screening protocol, and assessment criteria for HAC after pediatric LT?

The burden of participation is considered to be minimal, and limited to the questionnaires.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Liver transplantation between January 1st 2002 and January 1st 2022, diagnoses of HAC after LT
  • The age of the patient is below 18 years at the time of diagnosis and intervention
  • The date of diagnosis of HAC or intervention was before January 1st
  • HAC occurring after first or subsequent LTs are included.

排除标准

  • 未提供

研究组 & 干预措施

Conservative treatment

Surgical revascularization

Endovascular revascularization

Re-transplantation

结局指标

主要结局

Graft survival

时间窗: 1-1-2001 and 1-1-2023

Graft survival is defined as a functioning graft from transplantation to the end of follow-up data, re-transplantation, or death, whichever occurs first.

Patient survival

时间窗: 1-1-2001 and 1-1-2023

Patient survival is defined from the date of the primary LT until date of death. Causes of re-transplantation or death will be recorded.

次要结局

  • Incidence(1-1-2001 and 1-1-2023)
  • Technical success(1-1-2001 and 1-1-2023)
  • Intra- and post-procedural complications(1-1-2001 and 1-1-2023)
  • Primary and secondary patency(1-1-2001 and 1-1-2023)
  • Anticoagulant therapy after transplantation and after interventions(1-1-2001 and 1-1-2023)
  • Center specific screening protocol(1-1-2001 and 1-1-2023)
  • Center specific diagnostic criteria(1-1-2001 and 1-1-2023)
  • Center specific radiological follow up(1-1-2001 and 1-1-2023)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验